Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Sells $82,189.44 in Stock

Kewaunee Scientific Co. (NASDAQ:KEQUGet Free Report) CEO Thomas David Hull III sold 1,368 shares of Kewaunee Scientific stock in a transaction on Friday, January 10th. The stock was sold at an average price of $60.08, for a total transaction of $82,189.44. Following the transaction, the chief executive officer now directly owns 41,129 shares of the company’s stock, valued at $2,471,030.32. The trade was a 3.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Thomas David Hull III also recently made the following trade(s):

  • On Thursday, December 26th, Thomas David Hull III sold 2,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $63.01, for a total transaction of $126,020.00.

Kewaunee Scientific Stock Down 4.4 %

NASDAQ:KEQU opened at $55.20 on Tuesday. Kewaunee Scientific Co. has a twelve month low of $27.00 and a twelve month high of $67.20. The company has a market cap of $158.53 million, a price-to-earnings ratio of 8.75 and a beta of 0.72. The stock has a fifty day simple moving average of $48.78 and a 200-day simple moving average of $45.11. The company has a current ratio of 2.53, a quick ratio of 2.00 and a debt-to-equity ratio of 0.48.

Analysts Set New Price Targets

Separately, StockNews.com raised shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a research note on Wednesday, December 18th.

Read Our Latest Report on KEQU

Institutional Trading of Kewaunee Scientific

Several institutional investors and hedge funds have recently made changes to their positions in KEQU. Dimensional Fund Advisors LP lifted its position in shares of Kewaunee Scientific by 3.6% during the second quarter. Dimensional Fund Advisors LP now owns 177,548 shares of the technology company’s stock worth $8,378,000 after purchasing an additional 6,132 shares during the last quarter. Renaissance Technologies LLC lifted its position in shares of Kewaunee Scientific by 13.4% during the second quarter. Renaissance Technologies LLC now owns 89,611 shares of the technology company’s stock worth $4,230,000 after purchasing an additional 10,580 shares during the last quarter. Heron Bay Capital Management bought a new stake in shares of Kewaunee Scientific during the second quarter worth $252,000. Ritholtz Wealth Management raised its holdings in shares of Kewaunee Scientific by 24.6% in the third quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock valued at $363,000 after acquiring an additional 2,156 shares in the last quarter. Finally, De Lisle Partners LLP raised its holdings in shares of Kewaunee Scientific by 36.6% in the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after acquiring an additional 11,511 shares in the last quarter. 32.69% of the stock is currently owned by institutional investors.

About Kewaunee Scientific

(Get Free Report)

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

See Also

Insider Buying and Selling by Quarter for Kewaunee Scientific (NASDAQ:KEQU)

Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.